These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35036508)

  • 21. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
    Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of radical doses of pelvic radiotherapy for primary tumor treatment in patients with newly diagnosed organ metastatic cervical cancer.
    Yin Z; Lou H; Tang H; Ni J; Zhou Q; Chen M
    Radiat Oncol; 2019 May; 14(1):82. PubMed ID: 31109371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of Recurrence in Node-Positive Cervical Cancer Patients Treated With Contemporary Chemoradiation and Dose Escalation: A Multi-Institutional Study.
    Sethi R; Mayadev J; Sethi S; Rash D; Chen LM; Brooks R; Ueda S; Hsu IC
    Pract Radiat Oncol; 2019 Mar; 9(2):e180-e186. PubMed ID: 30342181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. External beam boost irradiation for clinically positive pelvic nodes in patients with uterine cervical cancer.
    Ariga T; Toita T; Kasuya G; Nagai Y; Inamine M; Kudaka W; Kakinohana Y; Aoki Y; Murayama S
    J Radiat Res; 2013 Jul; 54(4):690-6. PubMed ID: 23365264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors for pathological parametrial invasion in clinical stage IIB cervical cancer.
    Matsuo K; Shimada M; Nakamura K; Takei Y; Ushijima K; Sumi T; Ohara T; Yahata H; Mikami M; Sugiyama T
    Eur J Surg Oncol; 2019 Aug; 45(8):1417-1424. PubMed ID: 30846298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma.
    Werner-Wasik M; Schmid CH; Bornstein L; Ball HG; Smith DM; Madoc-Jones H
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1309-17. PubMed ID: 7635770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant pelvic irradiation in patients with pathologic T2b carcinoma of the uterine cervix.
    Uno T; Ito H; Itami J; Sato T; Minoura S; Yasuda S; Aruga T; Isobe K; Shigematsu N; Kubo A
    Int J Gynecol Cancer; 2002; 12(2):187-91. PubMed ID: 11975678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
    Lerouge D; Touboul E; Lefranc JP; Uzan S; Jannet D; Moureau-Zabotto L; Genestie C; Antoine M; Jamali M
    Cancer Radiother; 2004 Jun; 8(3):168-77. PubMed ID: 15217584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonrandomized evaluation of pelvic lymph node irradiation in localized carcinoma of the prostate.
    Perez CA; Michalski J; Brown KC; Lockett MA
    Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):573-84. PubMed ID: 8948341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fractionation in medium dose rate brachytherapy of cancer of the cervix.
    Leborgne F; Fowler JF; Leborgne JH; Zubizarreta E; Chappell R
    Int J Radiat Oncol Biol Phys; 1996 Jul; 35(5):907-14. PubMed ID: 8751399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term results of chemoradiation plus pulsed-dose-rate brachytherapy boost in anal canal carcinoma: A mono-institutional retrospective analysis.
    Arcelli A; Buwenge M; Macchia G; Cammelli S; Deodato F; Cilla S; Galuppi A; Panni V; Mattiucci GC; Tagliaferri L; Morganti AG
    J Contemp Brachytherapy; 2019 Feb; 11(1):21-27. PubMed ID: 30911306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postoperative pelvic radiotherapy for cervical cancer patients with positive parametrial invasion.
    Uno T; Ito H; Isobe K; Kaneyasu Y; Tanaka N; Mitsuhashi A; Suzuka K; Yamazawa K; Shigematsu N; Itami J
    Gynecol Oncol; 2005 Feb; 96(2):335-40. PubMed ID: 15661218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concomitant cervical and transperineal parametrial high-dose-rate brachytherapy boost for locally advanced cervical cancer.
    Bailleux C; Falk AT; Chand-Fouche ME; Gautier M; Barranger E; Hannoun-Levi JM
    J Contemp Brachytherapy; 2016 Feb; 8(1):23-31. PubMed ID: 26985194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
    Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
    BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus.
    Gkika E; Gauler T; Eberhardt W; Stahl M; Stuschke M; Pöttgen C
    Dis Esophagus; 2014; 27(7):678-84. PubMed ID: 24147973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-Term Outcomes of Cervical Cancer Patients Treated With Definitive Chemoradiation Following a Complete Metabolic Response.
    Lin AJ; Dehdashti F; Massad LS; Thaker PH; Powell MA; Mutch DG; Schwarz JK; Markovina S; Siegel BA; Grigsby PW
    Clin Oncol (R Coll Radiol); 2021 May; 33(5):300-306. PubMed ID: 33581976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of uterine cervical cancer patients with pelvic lymph node metastases after radiotherapy without boost irradiation of metastases.
    Yoshizawa E; Koiwai K; Ina H; Fukazawa A; Sakai K; Ozawa T; Matsushita H; Kadoya M
    J Obstet Gynaecol Res; 2017 Apr; 43(4):718-722. PubMed ID: 28127834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of vaginal brachytherapy boost following adjuvant external beam radiotherapy in cervical cancer: Turkish Society for Radiation Oncology Gynecologic Group Study (TROD 04-002).
    Gultekin M; Beduk Esen CS; Balci B; Alanyali S; Akkus Yildirim B; Guler OC; Yuce Sari S; Ergen SA; Sahinler I; Alsan Cetin I; Onal C; Yildiz F; Ozsaran Z
    Int J Gynecol Cancer; 2021 Feb; 31(2):185-193. PubMed ID: 32998860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
    Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.